Omnicell (NASDAQ: OMCL) — Perfil da empresa, notícias e dados financeiros
Omnicell specializes in medication and supply management solutions to enhance efficiency and patient care in healthcare.
Omnicell
Omnicell (NASDAQ:OMCL) specializes in medication and supply management solutions, offering a wide range of products and services aimed at improving healthcare efficiency and patient care. This company focuses on developing innovative pharmacy automation, analytics, and medication adherence solutions, helping healthcare facilities manage and optimize their medication dispensing and supply chain processes. With a strong commitment to technology and innovation, Omnicell's projects aim to reduce errors, enhance efficiency, and promote safety within the healthcare industry. Their objectives are centered on transforming the pharmacy care delivery model, ensuring that healthcare providers have the tools and data necessary to offer the best possible care to their patients.
Resumo
Operações
Produtos e/ou serviços de Omnicell
- Automated medication dispensing systems to enhance efficiency and safety in healthcare settings.
- Central pharmacy robotic systems for accurate and timely medication distribution.
- Point-of-care automation solutions for secure medication management at bedside.
- IV compounding systems and robotics ensuring precise and safe preparation of intravenous medications.
- Pharmacy analytics tools for data-driven decisions in hospital and retail pharmacies.
- Cloud-based software platforms for comprehensive pharmacy management and interconnectivity.
equipe executiva do Omnicell
- Randall A. LippsFounder, Executive Chairman & CEO
- Nnamdi N. NjokuPresident & COO
- H. Baird Radford IIIExecutive VP & CFO
- Corey J. ManleyExecutive VP, Chief Legal & Administrative Officer and Corporate Secretary
- Brian H. NuttVP, Chief Accounting Officer & Corporate Controller
- Perry A. GenovaSenior VP & CTO
- David UngerVice President of Investor Relations
- Tomer StavitskySenior VP & Chief Corporate Development Officer
- Stella PrefachSenior VP & Chief Marketing Officer
- Dave FordSVP & Chief People Officer
Principais indicadores financeiros
Resultados divulgados pela Omnicell, em USD.
- Cap. de mercado
- 1,6 bi
- Receita (TTM)
- 1,2 bi
- P/L
- 42.8
- LPA (diluído, TTM)
- 0.8
- Dividend yield
- —
- Margem de lucro
- 3.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,2 bi | 11,7 mi | 2,1 mi | |
| 1,1 bi | 337 mil | 12,5 mi | |
| 1,1 bi | -34,9 mi | -20,4 mi | |
| 1,3 bi | -2,3 mi | 5,6 mi |